Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 325 participants.

Also called NCT01728116

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 325 participants (enrolled count) (from the registry)
Sponsor
Morphic Medical Inc. (from the registry)
Registry
  • NCT NCT01728116
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01728116. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2016-02 (actual). Results posted on 2016-12-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
Acronym
ENDO
Condition
Obesity
Intervention (Device)
EndoBarrier
Intervention (Procedure)
Sham Procedure
Lead sponsor
Morphic Medical Inc. (class: industry)

Record details

Record id
cardio:ct-nct01728116
Content hash
cd2002d8784853b1e6b813e439ac85c0a2b8c82ec1add7048f6ec399bfb5da8c